Overview

DETERMINE: Detemir vs NPH

Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, Los Angeles
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human